Nuclear bile acid receptor FXR in the hepatic regeneration

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 8, 2011, Pages 888-892

  Chen, Wei Dong ^a   Wang, Yan Dong ^a   Meng, Zhipeng ^a   Zhang, Lisheng ^a   Huang, Wendong ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Bile acid; FXR; Liver regeneration; Liver repair; Nuclear receptor

Indexed keywords

BILE ACID; FARNESOID X RECEPTOR; GLUCOSE; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

AGING; BILE ACID METABOLISM; CELL CYCLE REGULATION; CELL PROLIFERATION; GLUCOSE METABOLISM; LIPID METABOLISM; LIVER INJURY; LIVER METABOLISM; LIVER REGENERATION; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

AGING; ANIMALS; BILE ACIDS AND SALTS; HUMANS; LIVER REGENERATION; MICE; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 79958273142     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.12.006     Document Type: Review

References (65)

1. Higgins G.M., Anderson R.M. Experimental pathology of the liver. Arch. Pathol. 1931, 186-202.
2. Fausto N. Liver regeneration. J. Hepatol. 2000, 32:19-31.
3. Taub R. Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 2004, 5:836-847.
4. Michalopoulos G.K. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am. J. Pathol. 2010, 176:2-13.
5. Costa R.H., Kalinichenko V.V., Holterman A.X., Wang X. Transcription factors in liver development, differentiation, and regeneration. Hepatology 2003, 38:1331-1347.
6. Chen W.D., Wang Y.D., Zhang L., Shiah S., Wang M., Yang F., Yu D., Forman B.M., Huang W. Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription. Hepatology 2010, 51:953-962.
7. Fortner J.G., Lincer R.M. Hepatic resection in the elderly. Ann. Surg. 1990, 211:141-145.
8. Koperna T., Kisser M., Schulz F. Hepatic resection in the elderly. World J. Surg. 1998, 22:406-412.
9. Iakova P., Awad S.S., Timchenko N.A. Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest. Cell 2003, 113:495-506.
10. Wang G.L., Shi X., Salisbury E., Sun Y., Albrecht J.H., Smith R.G., Timchenko N.A. Growth hormone corrects proliferation and transcription of phosphoenolpyruvate carboxykinase in livers of old mice via elimination of CCAAT/enhancer-binding protein alpha-Brm complex. J. Biol. Chem. 2007, 282:1468-1478.
11. Forman B.M., Goode E., Chen J., Oro A.E., Bradley D.J., Perlmann T., Noonan D.J., Burka L.T., McMorris T., Lamph W.W., Evans R.M., Weinberger C. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 1995, 81:687-693.
12. Bishop-Bile acidiley D., Walsh D.T., Warner T.D. Expression and activation of the farnesoid X receptor in the vasculature. Proc. Natl Acad. Sci. USA 2004, 101:3668-3673.
13. Zhang Y., Kast-Woelbern H.R., Edwards P.A. Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation. J. Biol. Chem. 2003, 278:104-110.
14. Huber R.M., Murphy K., Miao B., Link J.R., Cunningham M.R., Rupar M.J., Gunyuzlu P.L., Haws T.F., Kassam A., Powell F., Hollis G.F., Young P.R., Mukherjee R., Burn T.C. Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters. Gene 2002, 290:35-43.
15. Huang W., Ma K., Zhang J., Qatanani M., Cuvillier J., Liu J., Dong B., Huang X., Moore D.D. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 2006, 312:233-236.
16. Wang Y.D., Chen W.D., Huang W. FXR, a target for different diseases. Histol. Histopathol. 2008, 23:621-627.
17. Wang Y.D., Chen W.D., Moore D.D., Huang W. FXR: a metabolic regulator and cell protector. Cell Res. 2008, 18:1087-1095.
18. Wang Y.D., Chen W.D., Wang M., Yu D., Forman B.M., Huang W. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response. Hepatology 2008, 48:1632-1643.
19. Wang Y.D., Yang F., Chen W.D., Huang X., Lai L., Forman B.M., Huang W. Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo. Mol. Endocrinol. 2008, 22:1622-1632.
20. Makishima M., Okamoto A.Y., Repa J.J., Tu H., Learned R.M., Luk A., Hull M.V., Lustig K.D., Mangelsdorf D.J., Shan B. Identification of a nuclear receptor for bile acid. Science 1999, 284:1362-1365.
21. Parks D.J., Blanchard S.G., Bledsoe R.K., Chandra G., Consler T.G., Kliewer S.A., Stimmel J.B., Willson T.M., Zavacki A.M., Moore D.D., Lehmann J.M. Bile acid: natural ligands for an orphan nuclear receptor. Science 1999, 284:1365-1368.
22. Lee F.Y., Lee H., Hubbert M.L., Edwards P.A., Zhang Y. FXR, a multipurpose nuclear receptor. Trends Biochem. Sci. 2006, 31:572-580.
23. Zhang Y., Edwards P.A. FXR signaling in metabolic disease. FEBS Lett. 2008, 582:10-18.
24. Modica S., Moschetta A. Nuclear bile acid receptor FXR as pharmacological target: are we there yet?. FEBS Lett. 2006, 580:5492-5499.
25. Claudel T., Staels B., Kuipers F. The farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2020-2030.
26. Cariou B., Staels B. FXR: a promising target for the metabolic syndrome?. Trends Pharmacol. Sci. 2007, 28:236-243.
27. Grober J., Zaghini I., Fujii H., Jones S.A., Kliewer S.A., Willson T.M., Ono T., Besnard P. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer. J. Biol. Chem. 1999, 274:29749-29754.
28. Goodwin B., Jones S.A., Price R.R., Watson M.A., McKee D.D., Moore L.B., Galardi C., Wilson J.G., Lewis M.C., Roth M.E., Maloney P.R., Willson T.M., Kliewer S.A. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 2000, 6:517-526.
29. Sinal C.J., Tohkin M., Miyata M., Ward J.M., Lambert G., Gonzalez F.J. Targeted disruption of the nuclear receptor FXR/BILE ACIDR impairs bile acid and lipid homeostasis. Cell 2000, 102:731-744.
30. Edwards P.A., Kast H.R., Anisfeld A.M. BILE ACIDREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J. Lipid Res. 2002, 43:2-12.
31. Zhang Y., Castellani L.W., Sinal C.J., Gonzalez F.J., Edwards P.A. Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev. 2004, 18:157-169.
32. Li J., Pircher P.C., Schulman I.G., Westin S.K. Regulation of complement C3 expression by the bile acid receptor FXR. J. Biol. Chem. 2005, 280:7427-7434.
33. Urizar N.L., Dowhan D.H., Moore D.D. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J. Biol. Chem. 2000, 275:39313-39317.
34. Anisfeld A.M., Kast-Woelbern H.R., Meyer M.E., Jones S.A., Zhang Y., Williams K.J., Willson T., Edwards P.A. Syndecan-1 expression is regulated in an isoform-specific manner by the farnesoid-X receptor. J. Biol. Chem. 2003, 278:20420-20428.
35. Sirvent A., Claudel T., Martin G., Brozek J., Kosykh V., Darteil R., Hum D.W., Fruchart J.C., Staels B. The farnesoid X receptor induces very low density lipoprotein receptor gene expression. FEBS Lett. 2004, 566:173-177.
36. Claudel T., Sturm E., Duez H., Torra I.P., Sirvent A., Kosykh V., Fruchart J.C., Dallongeville J., Hum D.W., Kuipers F., Staels B. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element. J. Clin. Invest. 2002, 109:961-971.
37. Stayrook K.R., Bramlett K.S., Savkur R.S., Ficorilli J., Cook T., Christe M.E., Michael L.F., Burris T.P. Regulation of carbohydrate metabolism by the farnesoid X receptor. Endocrinology 2005, 146:984-991.
38. Fausto N., Campbell J.S., Riehle K.J. Liver regeneration. Hepatology 2006, 43:S45-S53.
39. Moolten F.L., Bucher N.L. Regeneration of rat liver: transfer of humoral agent by cross circulation. Science 1967, 158:272-274.
40. Lesurtel M., Graf R., Aleil B., Walther D.J., Tian Y., Jochum W., Gachet C., Bile acidder M., Clavien P.A. Platelet-derived serotonin mediates liver regeneration. Science 2006, 312:104-107.
41. Matondo R.B., Punt C., Homberg J., Toussaint M.J., Kisjes R., Korporaal S.J., Akkerman J.W., Cuppen E., de Bruin A. Deletion of the serotonin transporter in rats disturbs serotonin homeostasis without impairing liver regeneration. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G963-G968.
42. Walters J.R. Bile acid are physiological ligands for a nuclear receptor. Gut 2000, 46:308-309.
43. Columbile acidno A., Ledda-Columbile acidno G.M. Mitogenesis by ligands of nuclear receptors: an attractive model for the study of the molecular mechanisms implicated in liver growth. Cell Death Differ. 2003, 10(Suppl 1):S19-S21.
44. Zhang J., Huang W., Qatanani M., Evans R.M., Moore D.D. The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity. J. Biol. Chem. 2004, 279:49517-49522.
45. Ueda J., Chijiiwa K., Nakano K., Zhao G., Tanaka M. Lack of intestinal bile results in delayed liver regeneration of normal rat liver after hepatectomy accompanied by impaired cyclin E-associated kinase activity. Surgery 2002, 131:564-573.
46. Setchell K.D., Rodrigues C.M., Clerici C., Solinas A., Morelli A., Gartung C., Boyer J. Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. Gastroenterology 1997, 112:226-235.
47. Sainz G.R., Monte M.J., Barbero E.R., Herrera M.C., Marin J.J. Bile secretion by the rat liver during synchronized regeneration. Int. J. Exp. Pathol. 1997, 78:109-116.
48. Zhang L., huang X., meng Z., Dong B., Shiah S., Moore D.D., Huang W. Significance and mechanism of CYP7a1 gene regulation during the acute phase of liver regeneration. Mol. Endocrinol. 2009, 23:137-145.
49. Meng Z., Wang Y., Wang L., Jin W., Liu N., Pan H., Liu L., Wagman L., Forman B.M., Huang W. FXR regulates liver repair after CCl4-induced toxic injury. Mol. Endocrinol. 2010, 24:886-897.
50. Yang F., Huang X., Yi T., Yen Y., Moore D.D., Huang W. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res. 2007, 67:863-867.
51. Kim I., Morimura K., Shah Y., Yang Q., Ward J.M., Gonzalez F.J. Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis 2007, 28:940-946.
52. Inagaki T., Choi M., Moschetta A., Peng L., Cummins C.L., McDonald J.G., Luo G., Jones S.A., Goodwin B., Richardson J.A., Gerard R.D., Repa J.J., Mangelsdorf D.J., Kliewer S.A. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2005, 2:217-225.
53. Fisher B., Gunduz N., Saffer E.A., Zheng S. Relation of estrogen and its receptor to rat liver growth and regeneration. Cancer Res. 1984, 44:2410-2415.
54. Imai T., Jiang M., Kastner P., Chambon P., Metzger D. Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity. Proc. Natl Acad. Sci. USA 2001, 98:4581-4586.
55. Yamamoto Y., Ono T., Dhar D.K., Yamanoi A., Tachibile acidna M., Tanaka T., Nagasue N. Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats. J. Gastroenterol. Hepatol. 2008, 23:930-937.
56. Dai G., He L., Bu P., Wan Y.J. Pregnane X receptor is essential for normal progression of liver regeneration. Hepatology 2008, 47:1277-1287.
57. Lopez-Fontal R., Zeini M., Traves P.G., Gomez-Ferreria M., Aranda A., Saez G.T., Cerda C., Martin-Sanz P., Hortelano S., Bosca L. Mice lacking thyroid hormone receptor Beta show enhanced apoptosis and delayed liver commitment for proliferation after partial hepatectomy. PLoS One 2010, 5:e8710.
58. A. Columbano, G.M. Ledda-Columbano, Mitogenesis by ligands of nuclear receptors: an attractive model for the study of the molecular mechanisms implicated in liver growth, Cell Death Differ. 10 (2003) S19-S21.
59. Wang X., Kiyokawa H., Dennewitz M.B., Costa R.H. The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc. Natl Acad. Sci. USA 2002, 99:16881-16886.
60. Wang X., Krupczak-Hollis K., Tan Y., Dennewitz M.B., Adami G.R., Costa R.H. Increased hepatic Forkhead Box M1B (FoxM1B) levels in old-aged mice stimulated liver regeneration through diminished p27Kip1 protein levels and increased Cdc25B expression. J. Biol. Chem. 2002, 277:44310-44316.
61. Wang X., Quail E., Hung N.J., Tan Y., Ye H., Costa R.H. Increased levels of forkhead box M1B transcription factor in transgenic mouse hepatocytes prevent age-related proliferation defects in regenerating liver. Proc. Natl Acad. Sci. USA 2001, 98:11468-11473.
62. Krupczak-Hollis K., Wang X., Dennewitz M.B., Costa R.H. Growth hormone stimulates proliferation of old-aged regenerating liver through forkhead box m1b. Hepatology 2003, 38:1552-1562.
63. Conboy I.M., Conboy M.J., Wagers A.J., Girma E.R., Weissman I.L., Rando T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 433:760-764.
64. Costa R.H. FoxM1 dances with mitosis. Nat. Cell Biol. 2005, 7:108-110.
65. Laoukili J., Stahl M., Medema R.H. FoxM1: at the crossroads of ageing and cancer. Biochim. Biophys. Acta 2007, 1775:92-102.